Status:
ACTIVE_NOT_RECRUITING
Feasibility, of Tele-rehabilitation Following COVID-19
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Conditions:
Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
Since initial reports of a novel coronavirus emerged from Hubei province, China, the world has been engulfed by a pandemic with over 3 million cases and 225,000 deaths by 30th April 2020. Health care ...
Detailed Description
STUDY AIMS AND OBJECTIVES Aim: To address the uncertainties relating to the design and conduct of a tele-rehabilitation programme and substantive phase 3 randomised controlled trial to evaluate its ef...
Eligibility Criteria
Inclusion
- 1\) Males and females aged ≥18 years.
- 2\) Suspected or confirmed COVID-19 requiring hospitalisation and either i) non- invasive respiratory support \[CPAP, HFNO, NIV\] or ii) invasive mechanical ventilation within 3 months of study recruitment.
- 3\) \> 4 weeks since hospital discharge / first positive COVID-19 swab (whichever is later) at time of screening
- 4\) mMRC dyspnoea grades 2 or more.
- 5\) Perceived limitation of activities compared with prior to COVID-19 hospitalisation (patient or investigators perception).
- 6\) Internet connection and access to a device that supports video calling.
- 7\) Able to give informed consent
Exclusion
- \- 1) Significant comorbid physical or mental illness considered by the investigator to:
- 2\) prevent engagement in modified exercise,
- 3\) impair the participants ability to follow instructions
- 4\) place the participant at undue risk during exercise training
- 5\) adversely affect the recovery or rehabilitation trajectory
- Unwilling or unable to consent or complete study measures.
- Current involvement in other interventional clinical trials relating to COVID-19 (e.g. clinical trial of an investigational medicinal product)
Key Trial Info
Start Date :
August 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04511962
Start Date
August 24 2020
End Date
December 31 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Castle Hill Hospital
Cottingham, East Yorkshire, United Kingdom, HU16 5JQ